Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/EIGER-BIOPHARMACEUTICALS--26727607/noticia/Eiger-interrumpir-el-estudio-de-un-f-rmaco-contra-la-hepatitis-44826928/?utm_source=whatsapp&utm_medium=social&utm_campaign=share